Prevalência de resistência a antimicrobianos em isolados ...

Prevalência de resistência a antimicrobianos em isolados ambientais de Escherichia coli e enterococos
Silva MF da, Tiago I, Veríssimo A, Boaventura R, Nunes OC and Manaia CM. Antibiotic resistance of
enterococci and related bacteria in an urban wastewater treatment plant. FEMS Microbiol Ecol. 2006;
55:322-329.
Silveira ME, Freitas AR, Peixe L and Novais C. Environmental spread of antibiotic molecules, antibiotic
resistance bacteria and genes: jigsaw pieces of public health problem. Revista Faculdade de Ciências da
Saúde. 2009; 6: 244-253.
Singh J and Arrieta AC. New Cephalosporins. Semin Pediatr Inf Dis. 1999;10(1):14-22
Stroganov OV, Chilov GG and Švedas VK. Force field parametrization for 6-aminopenicillanic acid. J
Mol Struc: TEOCHEM. 2003; 631(1-3):117-125.
Taylor NGH, Verner-Jeffreys DW and Baker-Austin C. Aquatic systems: maintaining, mixing and
mobilizing antimicrobial resistanse? Trends in Ecology and Evolution. 2011; 26(6):278-284.
Tenover FC. Mechanisms of Antimicrobial Resistance in Bacteria. Am J Med. 2006; 34 (5 suppl): S3-
S10;S64-73.
Uttley AH, Collins CH, Naidoo J and George RC. Vancomycin-resistant enterococci. Lancet. 1988; 1: 57-
58.
Videira, A. Engenharia Genética, Princípios e Aplicações. LIDEL - Edições técnicas, 2001.
Vieira MEC and Bordalo AA. The Douro estuary (Portugal): a mesotidal salt wedge. Oceanologia Acta.
2000;23(5):585-594.
Vollmer W and Bertsche U. Murein (peptidoglycan) structure, architecture and biosynthesis in
Escherichia coli. Biochim Biophys Acta. 2008;1778(9):1714-1734.
Waksman SA. and Woodruff HB. Streptothricin, a new selective bacteriostatic and bactericidal agent,
particularly active against gram-negative bacteria. Proc Soc Exptl Biol Med. 1942;49:207-210.
Wang M, Sahm DF, Jacoby GA and Hooper DC. Emerging plasmid-mediated quinolone resistance
associated with qnr gene in Klebsiella pneumoniae clinical isolates in the United States. Antimicrob
agents Chemother. 2004; 48(4):1295-1299.
Wasaznik A, Grinholc M and Bielawski KP. Active efflux as the multidrug resistance mechanism.
Postepy Hig Med Dosw. 2009;9(63):123-133
Wilke MS, Lovering AL and Strynadka NCJ. ß-Lactam antibiotic resistance:a current structural
perspective. Curr Opin Microbiol. 2005; 8:525-533.
Williams JD, Naber KG, Bryskier A, Hoiby N, Gould IM, Periti P, Giamarellou H. and Rouveix B.
Classification of oral cephalosporins. A matter for debate. Int J Antimicrob Agents. 2001;17:443-450.
Wilson WR. The Role of Fourth-Generation Cephalosporins in the Treatmente of Serious Infectious
Diseases in Hospitalized Patients. Diagn Microbiol Infect Dis. 1998;31:473-477.
Wright GD. Mechanisms of resistance to antibiotics. Curr Opin Chem Biol. 2003;7:563 – 569.
Wright GD. Antibiotic resistance in the environment: a link to the clinic. Curr Opin Microbiol.
2010;13:589-594.
Yim G, Huimi H and Davies J. The truth about antibiotics. Int J Med Microbiol. 2006;296:163-170.
Zgurskaya HI. Molecular analysis of efflux pump based antibiotic resistance. Int. J Med Microbiol. 2002;
292:95–105.
107